Misplaced Pages

Certoparin sodium

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from Certoparin) Pharmaceutical drug Pharmaceutical compound
Certoparin sodium
Clinical data
Trade namesSandoparin, Embolex
AHFS/Drugs.comInternational Drug Names
ATC code
  • none
Identifiers
CAS Number
DrugBank
ChemSpider
  • none
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.110.590 Edit this at Wikidata
Mono-Embolex®

Certoparin (trade names Sandoparin, Embolex) is an antithrombotic medication. It is a low molecular weight heparin, primarily active against factor Xa. Like other low molecular weight heparins, it is used to prevent deep venous thrombosis.

References

  1. Donadini MP, Ageno W, Guasti L, Squizzato A (July 2013). "Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies". Expert Opinion on Drug Metabolism & Toxicology. 9 (7): 901–9. doi:10.1517/17425255.2013.794787. PMID 23621639. S2CID 31020741.
Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01)
Antiplatelet drugs
Glycoprotein IIb/IIIa inhibitors
ADP receptor/P2Y12 inhibitors
Prostaglandin analogue (PGI2)
COX inhibitors
Thromboxane inhibitors
Phosphodiesterase inhibitors
Other
Anticoagulants
Vitamin K antagonists
(inhibit II, VII, IX, X)
Factor Xa inhibitors
(with some II inhibition)
Heparin group/
glycosaminoglycans/
(bind antithrombin)
Direct Xa inhibitors ("xabans")
Direct thrombin (IIa) inhibitors
Other
Thrombolytic drugs/
fibrinolytics
Non-medicinal


Stub icon

This drug article relating to the blood and blood forming organs is a stub. You can help Misplaced Pages by expanding it.

Categories: